Home » Newsletters » BioWorld Science

BioWorld Science

May 11, 2011

View Archived Issues

Sanofi-aventis presents highlights of first quarter of 2011

Novel tetracycline TP-2758 efficacious in models of urinary tract infections and pyelonephritis

New nicotinic acetylcholine alpha7 receptor agonists claimed

Novel agents for Gram-negative bacterial infections synthesized at Pfizer

Merck & Co. patents new inhibitors of Mdm2-p53 interaction

Cephalon begins phase I/II CEP-9722 trial in advanced solid tumors

Albany Medical School and Aegis Therapeutics join to develop peptide against breast cancer

Evotec achieves new milestone in Boehringer Ingelheim drug discovery alliance

AstraZeneca discloses preclinical data on AZD-5363, in phase I testing in solid tumors

VT-1129 shows benefit in model of cryptococcal meningitis

Pooled trial data show linaclotide improves symptoms of constipation

AZD-2066 reduces transient lower esophageal sphincter relaxations in healthy subjects

Concert Pharmaceuticals prepares new GABA(A) receptor modulators

New sepiapterin reductase inhibitors claimed

Pharmacyclics discloses new tyrosine-protein kinase BTK inhibitors

Gentium submits defibrotide MAA to EMA for hepatic VOD in stem cell transplant recipients

Phase III trial of istradefylline in Parkinson's disease meets primary endpoint

Roche seeks FDA and EMA approval for vemurafenib in metastatic melanoma

National Cancer Institute to sponsor phase I study of Reolysin in multiple myeloma

Results from Asian study of lurasidone in schizophrenia inadequate to support filing in Japan

Sosei gains Japanese rights to antifungal agent Loramyc from BioAlliance

Allos Therapeutics and Mundipharma to codevelop anticancer drug Folotyn

Takeda acquires exclusive rights to fomepizole in Japan from Paladin Labs

Swissmedic approves Novartis' Votubia for brain tumors associated with tuberous sclerosis

Galapagos commences second proof-of-mechanism phase I trial of GLPG-0778

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...